{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "30",
                "@year": "2023",
                "@timestamp": "2023-06-30T13:07:36.000036-04:00",
                "@month": "06"
            },
            "ait:date-sort": {
                "@day": "15",
                "@year": "2021",
                "@month": "01"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": [
                {
                    "xocs:funding-agency-matched-string": "Novartis Pharmaceuticals",
                    "xocs:funding-agency-acronym": "NPC",
                    "xocs:funding-agency": "Novartis Pharmaceuticals Corporation",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100008272",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Novartis Pharmaceuticals",
                    "xocs:funding-agency": "Novartis Pharmaceuticals Canada",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100009009",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6251999/"
                }
            ],
            "xocs:funding-addon-generated-timestamp": "2022-11-16T10:30:48.268Z",
            "xocs:funding-text": "We thank Audrey So, MD, and Karlo Dumaup, MD, from Healthcare Consultancy Group, LLC, for their medical editorial assistance with this manuscript, which was funded by Novartis Pharmaceuticals. This study was funded by Novartis Pharmaceuticals.",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Taiwan",
                            "@afid": "60073385",
                            "@country": "twn",
                            "city": "Taipei",
                            "organization": [
                                {"$": "Department of Oncology"},
                                {"$": "National Taiwan University Hospital"}
                            ],
                            "affiliation-id": {
                                "@afid": "60073385",
                                "@dptid": "113273045"
                            },
                            "@affiliation-instance-id": "2010900114-21b454b265081b0f79659cfa89bced16",
                            "ce:source-text": "Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.",
                            "@dptid": "113273045"
                        },
                        "author": [{
                            "ce:given-name": "Yen-Shen",
                            "preferred-name": {
                                "ce:given-name": "Yen Shen",
                                "ce:initials": "Y.S.",
                                "ce:surname": "Lu",
                                "ce:indexed-name": "Lu Y.S."
                            },
                            "@seq": "1",
                            "@author-instance-id": "2010900114-4313b10f3c4a005cb0adc80d515cbf18",
                            "ce:initials": "Y.-S.",
                            "@date-locked": "2023-01-13T07:53:53.660",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Lu",
                            "@auid": "7405478996",
                            "ce:indexed-name": "Lu Y.-S."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "South Korea",
                            "@afid": "124204628",
                            "@country": "kor",
                            "city": "Goyang",
                            "organization": [
                                {"$": "Center for Breast Cancer"},
                                {"$": "National Cancer Center"}
                            ],
                            "affiliation-id": {
                                "@afid": "124204628",
                                "@dptid": "124211584"
                            },
                            "@affiliation-instance-id": "2010900114-11bfdfd97b5c90c26e865e606f785fb0",
                            "ce:source-text": "Center for Breast Cancer, National Cancer Center, Goyang, Republic of Korea.",
                            "@dptid": "124211584"
                        },
                        "author": [{
                            "ce:given-name": "Keun Seok",
                            "preferred-name": {
                                "ce:given-name": "Keun Seok",
                                "ce:initials": "K.S.",
                                "ce:surname": "Lee",
                                "ce:indexed-name": "Lee K.S."
                            },
                            "@seq": "2",
                            "@author-instance-id": "2010900114-973546f7c3e34437eafbb2aa4b2b55a6",
                            "ce:initials": "K.S.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Lee",
                            "@auid": "17137276100",
                            "ce:indexed-name": "Lee K.S."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Taiwan",
                            "@afid": "60211913",
                            "@country": "twn",
                            "city": "Taipei",
                            "organization": [
                                {"$": "Division of Hematology/Oncology"},
                                {"$": "Shuang Ho Hospital"},
                                {"$": "Taipei Cancer Center"},
                                {"$": "Taipei Medical University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60211913",
                                    "@dptid": "126351973"
                                },
                                {"@afid": "60022095"}
                            ],
                            "@affiliation-instance-id": "2010900114-045c97fe719ec07af41337964f486533",
                            "ce:source-text": "Division of Hematology/Oncology, Shuang Ho Hospital and Taipei Cancer Center, Taipei Medical University, Taipei, Taiwan.",
                            "@dptid": "126351973"
                        },
                        "author": [{
                            "ce:given-name": "Tsu-Yi",
                            "preferred-name": {
                                "ce:given-name": "Tsu Yi",
                                "ce:initials": "T.Y.",
                                "ce:surname": "Chao",
                                "ce:indexed-name": "Chao T.Y."
                            },
                            "@seq": "3",
                            "@author-instance-id": "2010900114-6df0f62a89144cf7ca6378d7aaa10065",
                            "ce:initials": "T.-Y.",
                            "@date-locked": "2022-11-21T10:15:50.868",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Chao",
                            "@auid": "36766329400",
                            "ce:indexed-name": "Chao T.-Y."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Taiwan",
                            "@afid": "60013314",
                            "@country": "twn",
                            "city": "Taipei",
                            "organization": [
                                {"$": "Department of Surgery"},
                                {"$": "Taipei Veterans General Hospital"}
                            ],
                            "affiliation-id": {
                                "@afid": "60013314",
                                "@dptid": "105223956"
                            },
                            "@affiliation-instance-id": "2010900114-8c8cc6d1dea083310cbb0e040dbce98c",
                            "ce:source-text": "Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.",
                            "@dptid": "105223956"
                        },
                        "author": [{
                            "ce:given-name": "Ling-Ming",
                            "preferred-name": {
                                "ce:given-name": "Ling Ming",
                                "ce:initials": "L.M.",
                                "ce:surname": "Tseng",
                                "ce:indexed-name": "Tseng L.M."
                            },
                            "@seq": "4",
                            "@author-instance-id": "2010900114-59aaf4a7dbffac86acc4bb359a51769b",
                            "ce:initials": "L.-M.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Tseng",
                            "@auid": "7201526690",
                            "ce:indexed-name": "Tseng L.-M."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Taiwan",
                            "@afid": "60069716",
                            "@country": "twn",
                            "city": "Taipei",
                            "organization": [
                                {"$": "School of Medicine"},
                                {"$": "National Yang-Ming University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60069716",
                                "@dptid": "113285486"
                            },
                            "@affiliation-instance-id": "2010900114-68f95cd301b25c9585dbf53413f3a2d6",
                            "ce:source-text": "School of Medicine, National Yang-Ming University, Taipei, Taiwan.",
                            "@dptid": "113285486"
                        },
                        "author": [{
                            "ce:given-name": "Ling-Ming",
                            "preferred-name": {
                                "ce:given-name": "Ling Ming",
                                "ce:initials": "L.M.",
                                "ce:surname": "Tseng",
                                "ce:indexed-name": "Tseng L.M."
                            },
                            "@seq": "4",
                            "@author-instance-id": "2010900114-59aaf4a7dbffac86acc4bb359a51769b",
                            "ce:initials": "L.-M.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Tseng",
                            "@auid": "7201526690",
                            "ce:indexed-name": "Tseng L.-M."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60000881",
                            "@country": "tha",
                            "city": "Chiang Mai",
                            "organization": [
                                {"$": "Division of Radiation Oncology"},
                                {"$": "Department of Radiology"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chiang Mai University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60000881",
                                "@dptid": "109438113"
                            },
                            "@affiliation-instance-id": "2010900114-3bdab5a4caf747c0f79ee681102079db",
                            "ce:source-text": "Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.",
                            "@dptid": "109438113"
                        },
                        "author": [{
                            "ce:given-name": "Imjai",
                            "preferred-name": {
                                "ce:given-name": "Imjai",
                                "ce:initials": "I.",
                                "ce:surname": "Chitapanarux",
                                "ce:indexed-name": "Chitapanarux I."
                            },
                            "@seq": "5",
                            "@author-instance-id": "2010900114-92c59d5e4bebc0b674b9f80954e4f8fe",
                            "ce:initials": "I.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Chitapanarux",
                            "@auid": "55937935900",
                            "ce:indexed-name": "Chitapanarux I."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Taiwan",
                            "@afid": "60031913",
                            "@country": "twn",
                            "city": "Linkou, Taoyouan City",
                            "organization": [
                                {"$": "Breast Surgery Division"},
                                {"$": "Chang Gung Memorial Hospital"}
                            ],
                            "affiliation-id": {
                                "@afid": "60031913",
                                "@dptid": "125742712"
                            },
                            "@affiliation-instance-id": "2010900114-89dd1f7f0c842b4c0f9de103c0394c72",
                            "ce:source-text": "Breast Surgery Division, Chang Gung Memorial Hospital, Linkou, Taoyouan City, Taiwan.",
                            "@dptid": "125742712"
                        },
                        "author": [{
                            "ce:given-name": "Shin-Cheh",
                            "preferred-name": {
                                "ce:given-name": "Shin Cheh",
                                "ce:initials": "S.C.",
                                "ce:surname": "Chen",
                                "ce:indexed-name": "Chen S.C."
                            },
                            "@seq": "6",
                            "@author-instance-id": "2010900114-212592bf0d73fc83f0c682541bd07e98",
                            "ce:initials": "S.-C.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Chen",
                            "@auid": "7410261626",
                            "ce:indexed-name": "Chen S.-C."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Taiwan",
                            "@afid": "60031913",
                            "@country": "twn",
                            "city": "Kaohsiung City",
                            "organization": [
                                {"$": "Division of Hematology and Oncology"},
                                {"$": "Kaohsiung Chang Gung Memorial Hospital"}
                            ],
                            "affiliation-id": {
                                "@afid": "60031913",
                                "@dptid": "113695485"
                            },
                            "@affiliation-instance-id": "2010900114-b82b647936bfdb14b58b89686f003c17",
                            "ce:source-text": "Division of Hematology and Oncology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan.",
                            "@dptid": "113695485"
                        },
                        "author": [{
                            "ce:given-name": "Chien-Ting",
                            "preferred-name": {
                                "ce:given-name": "Chien Ting",
                                "ce:initials": "C.T.",
                                "ce:surname": "Liu",
                                "ce:indexed-name": "Liu C.T."
                            },
                            "@seq": "7",
                            "@author-instance-id": "2010900114-36a1c2c4de009fad4baf6cc488302448",
                            "ce:initials": "C.-T.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Liu",
                            "@auid": "55324343100",
                            "ce:indexed-name": "Liu C.-T."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "South Korea",
                            "@afid": "60115402",
                            "@country": "kor",
                            "city": "Seoul",
                            "organization": [
                                {"$": "Division of Medical Oncology"},
                                {"$": "Yonsei Cancer Center"}
                            ],
                            "affiliation-id": {
                                "@afid": "60115402",
                                "@dptid": "122182846"
                            },
                            "@affiliation-instance-id": "2010900114-e594bf9995b48358b294b84089ead7d8",
                            "ce:source-text": "Division of Medical Oncology, Yonsei Cancer Center, Seoul, South Korea.",
                            "@dptid": "122182846"
                        },
                        "author": [{
                            "ce:given-name": "Joohyuk",
                            "preferred-name": {
                                "ce:given-name": "Joohyuk",
                                "ce:initials": "J.",
                                "ce:surname": "Sohn",
                                "ce:indexed-name": "Sohn J."
                            },
                            "@seq": "8",
                            "@author-instance-id": "2010900114-8ecf22712253f06290f10c7e0a587ad9",
                            "ce:initials": "J.",
                            "@date-locked": "2021-05-05T08:38:43.495",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Sohn",
                            "@auid": "15045889800",
                            "ce:indexed-name": "Sohn J."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "South Korea",
                            "@afid": "60098516",
                            "@country": "kor",
                            "city": "Seongnam",
                            "organization": [
                                {"$": "Department of Internal Medicine"},
                                {"$": "Seoul National University Bundang Hospital"},
                                {"$": "Seoul National University College of Medicine"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60098516",
                                    "@dptid": "110154308"
                                },
                                {"@afid": "60000656"}
                            ],
                            "@affiliation-instance-id": "2010900114-b1f01a069c4329393eef45ced33c29d6",
                            "ce:source-text": "Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.",
                            "@dptid": "110154308"
                        },
                        "author": [{
                            "ce:given-name": "Jee Hyun",
                            "preferred-name": {
                                "ce:given-name": "Jee Hyun",
                                "ce:initials": "J.H.",
                                "ce:surname": "Kim",
                                "ce:indexed-name": "Kim J.H."
                            },
                            "@seq": "9",
                            "@author-instance-id": "2010900114-bafbb40bf1b765a81bef258a9e715ca7",
                            "ce:initials": "J.H.",
                            "@date-locked": "2021-04-20T12:42:42.015",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Kim",
                            "@auid": "56004266300",
                            "ce:indexed-name": "Kim J.H."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Taiwan",
                            "@afid": "60029238",
                            "@country": "twn",
                            "city": "Taipei",
                            "organization": [
                                {"$": "Department of Surgery"},
                                {"$": "Mackay Memorial Hospital"}
                            ],
                            "affiliation-id": {
                                "@afid": "60029238",
                                "@dptid": "104475594"
                            },
                            "@affiliation-instance-id": "2010900114-66845977e34d36a7ff87d481df403c1f",
                            "ce:source-text": "Department of Surgery, Mackay Memorial Hospital, Taipei, Taiwan.",
                            "@dptid": "104475594"
                        },
                        "author": [{
                            "ce:given-name": "Yuan-Ching",
                            "preferred-name": {
                                "ce:given-name": "Yuan Ching",
                                "ce:initials": "Y.C.",
                                "ce:surname": "Chang",
                                "ce:indexed-name": "Chang Y.C."
                            },
                            "@seq": "10",
                            "@author-instance-id": "2010900114-98eced9bf530cd14800449f0dd054590",
                            "ce:initials": "Y.-C.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Chang",
                            "@auid": "7501844206",
                            "ce:indexed-name": "Chang Y.-C."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Taiwan",
                            "@afid": "60006121",
                            "@country": "twn",
                            "city": "Taichung",
                            "organization": {"$": "Taichung Veterans General Hospital"},
                            "affiliation-id": {"@afid": "60006121"},
                            "@affiliation-instance-id": "2010900114-d9ab145d6d9d53c4207a3435dfddc7bf",
                            "ce:source-text": "Taichung Veterans General Hospital, Taichung, Taiwan."
                        },
                        "author": [{
                            "ce:given-name": "Youngsen",
                            "preferred-name": {
                                "ce:given-name": "Youngsen",
                                "ce:initials": "Y.",
                                "ce:surname": "Yang",
                                "ce:indexed-name": "Yang Y."
                            },
                            "@seq": "11",
                            "@author-instance-id": "2010900114-0aabb9662c9cc8a4e99586b8b152d16e",
                            "ce:initials": "Y.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Yang",
                            "@auid": "16403762600",
                            "ce:indexed-name": "Yang Y."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Therapeutic Radiology and Oncology"},
                                {"$": "Department of Radiology"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "113647143"
                            },
                            "@affiliation-instance-id": "2010900114-2371b49897c5671f1bc0e34ee56d03c8",
                            "ce:source-text": "Division of Therapeutic Radiology and Oncology, Department of Radiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.",
                            "@dptid": "113647143"
                        },
                        "author": [{
                            "ce:given-name": "Kanjana",
                            "preferred-name": {
                                "ce:given-name": "Kanjana",
                                "ce:initials": "K.",
                                "ce:surname": "Shotelersuk",
                                "ce:indexed-name": "Shotelersuk K."
                            },
                            "@seq": "12",
                            "@author-instance-id": "2010900114-d3a776662da16ad370f85ac730a407c0",
                            "ce:initials": "K.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Shotelersuk",
                            "@auid": "6602969622",
                            "ce:indexed-name": "Shotelersuk K."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "South Korea",
                            "@afid": "60006240",
                            "@country": "kor",
                            "city": "Seoul",
                            "organization": [
                                {"$": "Department of Oncology"},
                                {"$": "Asan Medical Center"},
                                {"$": "University of Ulsan College of Medicine"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60006240",
                                    "@dptid": "103354684"
                                },
                                {"@afid": "60068691"}
                            ],
                            "@affiliation-instance-id": "2010900114-8aa9956e7e6501301373cbb20b8fe9c8",
                            "ce:source-text": "Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.",
                            "@dptid": "103354684"
                        },
                        "author": [{
                            "ce:given-name": "Kyung Hae",
                            "preferred-name": {
                                "ce:given-name": "Kyung Hae",
                                "ce:initials": "K.H.",
                                "ce:surname": "Jung",
                                "ce:indexed-name": "Jung K.H."
                            },
                            "@seq": "13",
                            "@author-instance-id": "2010900114-6ae97a829321809d5cafc6381cb830e7",
                            "ce:initials": "K.H.",
                            "@date-locked": "2021-07-12T03:32:28.191",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Jung",
                            "@auid": "15765006000",
                            "ce:indexed-name": "Jung K.H."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Switzerland",
                            "@afid": "60009968",
                            "@country": "che",
                            "city": "Basel",
                            "organization": {"$": "Novartis Pharma AG"},
                            "affiliation-id": {"@afid": "60009968"},
                            "@affiliation-instance-id": "2010900114-9ed09b38350ebc67547d7379b90a724b",
                            "ce:source-text": "Novartis Pharma AG, Basel, Switzerland."
                        },
                        "author": [
                            {
                                "ce:given-name": "Roberta",
                                "preferred-name": {
                                    "ce:given-name": "Roberta",
                                    "ce:initials": "R.",
                                    "ce:surname": "Valenti",
                                    "ce:indexed-name": "Valenti R."
                                },
                                "@seq": "14",
                                "@author-instance-id": "2010900114-306c0eeb9d5bc4d287d4951f659fa5a5",
                                "ce:initials": "R.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Valenti",
                                "@auid": "57221831113",
                                "ce:indexed-name": "Valenti R."
                            },
                            {
                                "ce:given-name": "Cassandra",
                                "preferred-name": {
                                    "ce:given-name": "Cassandra",
                                    "ce:initials": "C.",
                                    "ce:surname": "Slader",
                                    "ce:indexed-name": "Slader C."
                                },
                                "@seq": "15",
                                "@author-instance-id": "2010900114-55bfae99548aae8f3f66612ca3c74e72",
                                "ce:initials": "C.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Slader",
                                "@auid": "57220568979",
                                "ce:indexed-name": "Slader C."
                            },
                            {
                                "ce:given-name": "Melissa",
                                "preferred-name": {
                                    "ce:given-name": "Melissa",
                                    "ce:initials": "M.",
                                    "ce:surname": "Gao",
                                    "ce:indexed-name": "Gao M."
                                },
                                "@seq": "16",
                                "@author-instance-id": "2010900114-09d8b8c726f39fdfb93044e27073979b",
                                "ce:initials": "M.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Gao",
                                "@auid": "57221834242",
                                "ce:indexed-name": "Gao M."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "South Korea",
                            "@afid": "60020857",
                            "@country": "kor",
                            "city": "Seoul",
                            "organization": [
                                {"$": "Division of Hematology-Oncology"},
                                {"$": "Department of Medicine"},
                                {"$": "Samsung Medical Center"}
                            ],
                            "affiliation-id": {
                                "@afid": "60020857",
                                "@dptid": "112830784"
                            },
                            "@affiliation-instance-id": "2010900114-a7203f55be94cb5af79081a63c9918cb",
                            "ce:source-text": "Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Seoul, South Korea.",
                            "@dptid": "112830784"
                        },
                        "author": [{
                            "ce:given-name": "Yeon Hee",
                            "preferred-name": {
                                "ce:given-name": "Yeon Hee",
                                "ce:initials": "Y.H.",
                                "ce:surname": "Park",
                                "ce:indexed-name": "Park Y.H."
                            },
                            "@seq": "17",
                            "@author-instance-id": "2010900114-2fed02055d9a4b939002ef034a62409e",
                            "ce:initials": "Y.H.",
                            "@date-locked": "2021-10-31T07:32:34.713",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Park",
                            "@auid": "56590167700",
                            "ce:indexed-name": "Park Y.H."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "South Korea",
                            "address-part": "50 Ilwon-dong Kangnam-gu",
                            "postal-code": "135-710",
                            "@afid": "60020857",
                            "@country": "kor",
                            "city": "Seoul",
                            "organization": [
                                {"$": "Samsung Medical Center"},
                                {"$": "South Korea"}
                            ],
                            "affiliation-id": {"@afid": "60020857"},
                            "@affiliation-instance-id": "2010900114-ca9b67526686b6fcc3d4679d6e7ef8c2",
                            "ce:source-text": "Corresponding Author: Yeon Hee Park, Samsung Medical Center, South Korea, 50 Ilwon-dong Kangnam-gu, Seoul 135-710, Republic of Korea (South). Phone: 822-3410-1780; Fax: 822-3410-1754;"
                        },
                        "author": [{
                            "ce:given-name": "Yeon Hee",
                            "preferred-name": {
                                "ce:given-name": "Yeon Hee",
                                "ce:initials": "Y.H.",
                                "ce:surname": "Park",
                                "ce:indexed-name": "Park Y.H."
                            },
                            "@seq": "17",
                            "@author-instance-id": "2010900114-2fed02055d9a4b939002ef034a62409e",
                            "ce:initials": "Y.H.",
                            "@date-locked": "2021-10-31T07:32:34.713",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Park",
                            "@auid": "56590167700",
                            "ce:indexed-name": "Park Y.H."
                        }]
                    }
                ],
                "citation-title": "A phase ib study of alpelisib or buparlisib combined with tamoxifen plus goserelin in premenopausal women with HR-positive HER2-negative advanced breast cancer",
                "abstracts": "© 2020 American Association for Cancer Research.Purpose: This study reports the MTD, recommended phase 2 ose (RP2D), and preliminary efficacy of alpelisib or buparlisib used n combination with tamoxifen plus goserelin in premenopausal atients with hormone receptor\u2013positive (HRþ), HER2-negative HER2) advanced breast cancer (ABC). Patients and Methods: This study enrolled premenopausal women with HRþ, HER2 ABC. Patients received tamoxifen (20 mg nce daily) and goserelin acetate (3.6 mg every 28 days) with either lpelisib (350 mg once daily; n ¼ 16) or buparlisib (100 mg once aily; n ¼ 13) in 28-day cycles until MTD was observed. Results: The criteria for MTD were not met for both alpelisib and uparlisib. The RP2D of alpelisib and buparlisib in combination with tamoxifen and goserelin were 350 mg and 100 mg, respectively. oth combinations met protocol-specified criteria for tolerability. The most common grade 3/4 treatment-emergent adverse events (TEAE) were hypokalemia (12.5%), hyperglycemia (6.3%), and rash (6.3%) for alpelisib and alanine aminotransferase increase (30.8%), aspartate aminotransferase increase (23.1%), and anxiety (15.4%) for buparlisib. TEAEs led to treatment discontinuation in 18.8% and 53.8% of alpelisib- and buparlisib-treated patients, respectively. Progression-free survival was 25.2 months in the alpelisib group and 20.6 months in the buparlisib group. Conclusions: The RP2Ds of alpelisib and buparlisib were 350 mg and 100 mg, respectively. No unexpected safety findings were reported. Although an early-phase study, data suggest that alpelisib plus endocrine therapy may be a potentially efficacious treatment that warrants further evaluation for premenopausal patients with HRþ, HER2 ABC.",
                "citation-info": {
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "https://clincancerres.aacrjournals.org/content/27/2/408.full-text.pdf",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "Clinical Cancer Research",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {
                        "voliss": {
                            "@volume": "27",
                            "@issue": "2"
                        },
                        "pagerange": {
                            "@first": "408",
                            "@last": "417"
                        }
                    },
                    "@type": "j",
                    "sourcetitle": "Clinical Cancer Research",
                    "publicationdate": {
                        "month": "01",
                        "year": "2021",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "15 January 2021"
                        },
                        "day": "15"
                    },
                    "codencode": "CCREF",
                    "sourcetitle-abbrev": "Clin. Cancer Res.",
                    "@country": "usa",
                    "issn": [
                        {
                            "$": "15573265",
                            "@type": "electronic"
                        },
                        {
                            "$": "10780432",
                            "@type": "print"
                        }
                    ],
                    "publicationyear": {"@first": "2021"},
                    "publisher": {"publishername": "American Association for Cancer Research Inc."},
                    "@srcid": "29263"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "CABSCLASS",
                            "classification": [
                                {
                                    "classification-code": "87.4.1.12",
                                    "classification-description": "CANCER RESEARCH; TREATMENT; Chemotherapy; Drug combinations"
                                },
                                {
                                    "classification-code": "87.5.11",
                                    "classification-description": "CANCER RESEARCH; CLINICAL INVESTIGATIONS BY ORGAN SITE; Breast"
                                }
                            ]
                        },
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "10",
                                    "classification-description": "Obstetrics and Gynecology"
                                },
                                {
                                    "classification-code": "16",
                                    "classification-description": "Cancer"
                                },
                                {
                                    "classification-code": "17",
                                    "classification-description": "Public Health, Social Medicine and Epidemiology"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "38",
                                    "classification-description": "Adverse Reactions Titles"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": "2700"
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": "MEDI"
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": [
                                {
                                    "cas-registry-number": [
                                        {"$": "9000-86-6"},
                                        {"$": "9014-30-6"}
                                    ],
                                    "enzyme-commission-number": "EC 2.6.1.2",
                                    "chemical-name": "alanine aminotransferase"
                                },
                                {
                                    "cas-registry-number": "1217486-61-7",
                                    "chemical-name": "alpelisib"
                                },
                                {
                                    "cas-registry-number": "9000-97-9",
                                    "enzyme-commission-number": "EC 2.6.1.1",
                                    "chemical-name": "aspartate aminotransferase"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "1202777-78-3"},
                                        {"$": "944396-07-0"},
                                        {"$": "1312445-63-8"}
                                    ],
                                    "chemical-name": "buparlisib"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "50-99-7"},
                                        {"$": "84778-64-3"}
                                    ],
                                    "chemical-name": "glucose"
                                },
                                {
                                    "cas-registry-number": "65807-02-5",
                                    "chemical-name": "goserelin"
                                },
                                {
                                    "cas-registry-number": "10540-29-1",
                                    "chemical-name": "tamoxifen"
                                },
                                {
                                    "cas-registry-number": "147014-97-9",
                                    "chemical-name": "cyclin dependent kinase 4"
                                },
                                {
                                    "cas-registry-number": "137632-09-8",
                                    "chemical-name": "epidermal growth factor receptor 2"
                                },
                                {
                                    "cas-registry-number": "115926-52-8",
                                    "enzyme-commission-number": "EC 2.7.1.137",
                                    "chemical-name": "phosphatidylinositol 3 kinase"
                                }
                            ]
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "Alpelisib"},
                                {"chemical-name": "Aminopyridines"},
                                {"chemical-name": "CDK4 protein, human"},
                                {"chemical-name": "Cyclin-Dependent Kinase 4"},
                                {"chemical-name": "Goserelin"},
                                {"chemical-name": "Morpholines"},
                                {"chemical-name": "NVP-BKM120"},
                                {"chemical-name": "Receptor, ErbB-2"},
                                {"chemical-name": "Tamoxifen"},
                                {"chemical-name": "Thiazoles"}
                            ]
                        }
                    ]}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "We thank Audrey So, MD, and Karlo Dumaup, MD, from Healthcare Consultancy Group, LLC, for their medical editorial assistance with this manuscript, which was funded by Novartis Pharmaceuticals. This study was funded by Novartis Pharmaceuticals.",
                        "@xml:lang": "eng"
                    }
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2021 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "Publisher",
                "dbcollection": [
                    {"$": "CABS"},
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "MOSYEA"},
                    {"$": "REAXYS"},
                    {"$": "REAXYSCAR"},
                    {"$": "RMC"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "03",
                    "@year": "2021",
                    "@timestamp": "BST 13:03:40",
                    "@month": "03"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2010900114",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "632476705",
                            "@idtype": "associatedPUI"
                        },
                        {
                            "$": "2021058173",
                            "@idtype": "CABS"
                        },
                        {
                            "$": "931169412",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20210130816",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "32718997",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "2021027632",
                            "@idtype": "MOSYEA"
                        },
                        {
                            "$": "2021039190",
                            "@idtype": "REAXYS"
                        },
                        {
                            "$": "20210596077",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "2021101585",
                            "@idtype": "RMC"
                        },
                        {
                            "$": "20210404158",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "20210326535066",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85100350018",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85100350018",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "632476705",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "76908399",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:doi": "10.1158/1078-0432.CCR-20-1008"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "43",
                "reference": [
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394\u2013424.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85053395052",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "68"},
                                "pagerange": {
                                    "@first": "394",
                                    "@last": "424"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "F",
                                    "@_fa": "true",
                                    "ce:surname": "Bray",
                                    "ce:indexed-name": "Bray F"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Ferlay",
                                    "ce:indexed-name": "Ferlay J"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "I",
                                    "@_fa": "true",
                                    "ce:surname": "Soerjomataram",
                                    "ce:indexed-name": "Soerjomataram I"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "RL",
                                    "@_fa": "true",
                                    "ce:surname": "Siegel",
                                    "ce:indexed-name": "Siegel RL"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "LA",
                                    "@_fa": "true",
                                    "ce:surname": "Torre",
                                    "ce:indexed-name": "Torre LA"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Jemal",
                                    "ce:indexed-name": "Jemal A."
                                }
                            ]},
                            "ref-sourcetitle": "CA Cancer J Clin"
                        },
                        "ce:source-text": "Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394\u2013424."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Lin CH, Yap YS, Lee KH, Im SA, Naito Y, Yeo W, et al. Contrasting epidemiology and clinicopathology of female breast cancer in Asians versus the US population. J Natl Cancer Inst 2019;111:1298\u20131306.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Contrasting epidemiology and clinicopathology of female breast cancer in Asians versus the US population"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85068867455",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "111"},
                                "pagerange": {
                                    "@first": "1298",
                                    "@last": "1306"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "CH",
                                        "@_fa": "true",
                                        "ce:surname": "Lin",
                                        "ce:indexed-name": "Lin CH"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "YS",
                                        "@_fa": "true",
                                        "ce:surname": "Yap",
                                        "ce:indexed-name": "Yap YS"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "KH",
                                        "@_fa": "true",
                                        "ce:surname": "Lee",
                                        "ce:indexed-name": "Lee KH"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "SA",
                                        "@_fa": "true",
                                        "ce:surname": "Im",
                                        "ce:indexed-name": "Im SA"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Naito",
                                        "ce:indexed-name": "Naito Y"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "W",
                                        "@_fa": "true",
                                        "ce:surname": "Yeo",
                                        "ce:indexed-name": "Yeo W"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Natl Cancer Inst"
                        },
                        "ce:source-text": "Lin CH, Yap YS, Lee KH, Im SA, Naito Y, Yeo W, et al. Contrasting epidemiology and clinicopathology of female breast cancer in Asians versus the US population. J Natl Cancer Inst 2019;111:1298\u20131306."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Youlden DR, Cramb SM, Yip CH, Baade PD. Incidence and mortality of female breast cancer in the Asia-Pacific region. Cancer Biol Med 2014;11:101\u201315.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Incidence and mortality of female breast cancer in the Asia-Pacific region"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84903901836",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "11"},
                                "pagerange": {
                                    "@first": "101",
                                    "@last": "115"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "DR",
                                    "@_fa": "true",
                                    "ce:surname": "Youlden",
                                    "ce:indexed-name": "Youlden DR"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "SM",
                                    "@_fa": "true",
                                    "ce:surname": "Cramb",
                                    "ce:indexed-name": "Cramb SM"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "CH",
                                    "@_fa": "true",
                                    "ce:surname": "Yip",
                                    "ce:indexed-name": "Yip CH"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "PD.",
                                    "@_fa": "true",
                                    "ce:surname": "Baade",
                                    "ce:indexed-name": "Baade PD."
                                }
                            ]},
                            "ref-sourcetitle": "Cancer Biol Med"
                        },
                        "ce:source-text": "Youlden DR, Cramb SM, Yip CH, Baade PD. Incidence and mortality of female breast cancer in the Asia-Pacific region. Cancer Biol Med 2014;11:101\u201315."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Yap YS, Lu YS, Tamura K, Lee JE, Ko EY, Park YH, et al. Insights into breast cancer in the east vs the west: a review. JAMA Oncol 2019;5:1489\u201396.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Insights into breast cancer in the east vs the west: a review"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85065802784",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "5"},
                                "pagerange": {
                                    "@first": "1489",
                                    "@last": "1496"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "YS",
                                        "@_fa": "true",
                                        "ce:surname": "Yap",
                                        "ce:indexed-name": "Yap YS"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "YS",
                                        "@_fa": "true",
                                        "ce:surname": "Lu",
                                        "ce:indexed-name": "Lu YS"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Tamura",
                                        "ce:indexed-name": "Tamura K"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "JE",
                                        "@_fa": "true",
                                        "ce:surname": "Lee",
                                        "ce:indexed-name": "Lee JE"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "EY",
                                        "@_fa": "true",
                                        "ce:surname": "Ko",
                                        "ce:indexed-name": "Ko EY"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "YH",
                                        "@_fa": "true",
                                        "ce:surname": "Park",
                                        "ce:indexed-name": "Park YH"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "JAMA Oncol"
                        },
                        "ce:source-text": "Yap YS, Lu YS, Tamura K, Lee JE, Ko EY, Park YH, et al. Insights into breast cancer in the east vs the west: a review. JAMA Oncol 2019;5:1489\u201396."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Blows FM, Driver KE, Schmidt MK, Broeks A, van Leeuwen FE, Wesseling J, et al. Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies. PLoS Med 2010;7:e1000279.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies"},
                            "refd-itemidlist": {"itemid": {
                                "$": "77953248475",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {"@first": "e1000279"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "FM",
                                        "@_fa": "true",
                                        "ce:surname": "Blows",
                                        "ce:indexed-name": "Blows FM"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "KE",
                                        "@_fa": "true",
                                        "ce:surname": "Driver",
                                        "ce:indexed-name": "Driver KE"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "MK",
                                        "@_fa": "true",
                                        "ce:surname": "Schmidt",
                                        "ce:indexed-name": "Schmidt MK"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Broeks",
                                        "ce:indexed-name": "Broeks A"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "FE",
                                        "@_fa": "true",
                                        "ce:surname": "van Leeuwen",
                                        "ce:indexed-name": "van Leeuwen FE"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Wesseling",
                                        "ce:indexed-name": "Wesseling J"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "PLoS Med"
                        },
                        "ce:source-text": "Blows FM, Driver KE, Schmidt MK, Broeks A, van Leeuwen FE, Wesseling J, et al. Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies. PLoS Med 2010;7:e1000279."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "American Cancer Society. Breast cancer facts & figures 2017-2018. Atlanta: American Cancer Society, Inc.; 2017.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85040371731",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "American Cancer Society. Atlanta: American Cancer Society, Inc",
                            "ref-sourcetitle": "Breast cancer facts & figures 2017-2018"
                        },
                        "ce:source-text": "American Cancer Society. Breast cancer facts & figures 2017-2018. Atlanta: American Cancer Society, Inc.; 2017."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Hortobagyi GN, Stemmer SM, Burris HA, Yap YS, Sonke GS, Paluch-Shimon S, et al. Ribociclib as first-line therapy for HR-positive, advanced breast cancer. N Engl J Med 2016;375:1738\u201348.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Ribociclib as first-line therapy for HR-positive, advanced breast cancer"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84994151988",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "375"},
                                "pagerange": {
                                    "@first": "1738",
                                    "@last": "1748"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "GN",
                                        "@_fa": "true",
                                        "ce:surname": "Hortobagyi",
                                        "ce:indexed-name": "Hortobagyi GN"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "SM",
                                        "@_fa": "true",
                                        "ce:surname": "Stemmer",
                                        "ce:indexed-name": "Stemmer SM"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "HA",
                                        "@_fa": "true",
                                        "ce:surname": "Burris",
                                        "ce:indexed-name": "Burris HA"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "YS",
                                        "@_fa": "true",
                                        "ce:surname": "Yap",
                                        "ce:indexed-name": "Yap YS"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "GS",
                                        "@_fa": "true",
                                        "ce:surname": "Sonke",
                                        "ce:indexed-name": "Sonke GS"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Paluch-Shimon",
                                        "ce:indexed-name": "Paluch-Shimon S"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Hortobagyi GN, Stemmer SM, Burris HA, Yap YS, Sonke GS, Paluch-Shimon S, et al. Ribociclib as first-line therapy for HR-positive, advanced breast cancer. N Engl J Med 2016;375:1738\u201348."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Finn RS, Martin M, Rugo HS, Jones S, Im S-A, Gelmon K, et al. Palbociclib and letrozole in advanced breast cancer. N Engl J Med 2016;375:1925\u201336.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Palbociclib and letrozole in advanced breast cancer"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84995633338",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "375"},
                                "pagerange": {
                                    "@first": "1925",
                                    "@last": "1936"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "RS",
                                        "@_fa": "true",
                                        "ce:surname": "Finn",
                                        "ce:indexed-name": "Finn RS"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Martin",
                                        "ce:indexed-name": "Martin M"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "HS",
                                        "@_fa": "true",
                                        "ce:surname": "Rugo",
                                        "ce:indexed-name": "Rugo HS"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Jones",
                                        "ce:indexed-name": "Jones S"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "S-A",
                                        "@_fa": "true",
                                        "ce:surname": "Im",
                                        "ce:indexed-name": "Im S-A"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Gelmon",
                                        "ce:indexed-name": "Gelmon K"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Finn RS, Martin M, Rugo HS, Jones S, Im S-A, Gelmon K, et al. Palbociclib and letrozole in advanced breast cancer. N Engl J Med 2016;375:1925\u201336."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Goetz MP, Toi M, Campone M, Sohn J, Paluch-Shimon S, Huober J, et al. MONARCH 3: abemaciclib as initial therapy for advanced breast cancer. J Clin Oncol 2017;35:3638\u201346.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "MONARCH 3: abemaciclib as initial therapy for advanced breast cancer"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85032984371",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "35"},
                                "pagerange": {
                                    "@first": "3638",
                                    "@last": "3646"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "MP",
                                        "@_fa": "true",
                                        "ce:surname": "Goetz",
                                        "ce:indexed-name": "Goetz MP"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Toi",
                                        "ce:indexed-name": "Toi M"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Campone",
                                        "ce:indexed-name": "Campone M"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Sohn",
                                        "ce:indexed-name": "Sohn J"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Paluch-Shimon",
                                        "ce:indexed-name": "Paluch-Shimon S"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Huober",
                                        "ce:indexed-name": "Huober J"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Goetz MP, Toi M, Campone M, Sohn J, Paluch-Shimon S, Huober J, et al. MONARCH 3: abemaciclib as initial therapy for advanced breast cancer. J Clin Oncol 2017;35:3638\u201346."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Cardoso F, Senkus E, Costa A, Papadopoulos E, Aapro M, Andre F, et al. 4th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 4). Ann Oncol 2018;29:1634\u201357.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "4th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 4)"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85053909898",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "29"},
                                "pagerange": {
                                    "@first": "1634",
                                    "@last": "1657"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Cardoso",
                                        "ce:indexed-name": "Cardoso F"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Senkus",
                                        "ce:indexed-name": "Senkus E"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Costa",
                                        "ce:indexed-name": "Costa A"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Papadopoulos",
                                        "ce:indexed-name": "Papadopoulos E"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Aapro",
                                        "ce:indexed-name": "Aapro M"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Andre",
                                        "ce:indexed-name": "Andre F"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Cardoso F, Senkus E, Costa A, Papadopoulos E, Aapro M, Andre F, et al. 4th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 4). Ann Oncol 2018;29:1634\u201357."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Im SA, Lu YS, Bardia A, Harbeck N, Colleoni M, Franke F, et al. Overall survival with ribociclib plus endocrine therapy in breast cancer. N Engl J Med 2019;381: 307\u201316.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Overall survival with ribociclib plus endocrine therapy in breast cancer"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85068361995",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "381"},
                                "pagerange": {
                                    "@first": "307",
                                    "@last": "316"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "SA",
                                        "@_fa": "true",
                                        "ce:surname": "Im",
                                        "ce:indexed-name": "Im SA"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "YS",
                                        "@_fa": "true",
                                        "ce:surname": "Lu",
                                        "ce:indexed-name": "Lu YS"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Bardia",
                                        "ce:indexed-name": "Bardia A"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Harbeck",
                                        "ce:indexed-name": "Harbeck N"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Colleoni",
                                        "ce:indexed-name": "Colleoni M"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Franke",
                                        "ce:indexed-name": "Franke F"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Im SA, Lu YS, Bardia A, Harbeck N, Colleoni M, Franke F, et al. Overall survival with ribociclib plus endocrine therapy in breast cancer. N Engl J Med 2019;381: 307\u201316."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Tripathy D, Im SA, Colleoni M, Franke F, Bardia A, Harbeck N, et al. Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial. Lancet Oncol 2018;19:904\u201315.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85047257394",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "19"},
                                "pagerange": {
                                    "@first": "904",
                                    "@last": "915"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Tripathy",
                                        "ce:indexed-name": "Tripathy D"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "SA",
                                        "@_fa": "true",
                                        "ce:surname": "Im",
                                        "ce:indexed-name": "Im SA"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Colleoni",
                                        "ce:indexed-name": "Colleoni M"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Franke",
                                        "ce:indexed-name": "Franke F"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Bardia",
                                        "ce:indexed-name": "Bardia A"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Harbeck",
                                        "ce:indexed-name": "Harbeck N"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Tripathy D, Im SA, Colleoni M, Franke F, Bardia A, Harbeck N, et al. Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial. Lancet Oncol 2018;19:904\u201315."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology - breast cancer; 2019. Available from: https://www.nccn.org/store/login/login.aspx?ReturnURL=https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.nccn.org/store/login/login.aspx?ReturnURL=https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "79952721582",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "National Comprehensive Cancer Network",
                            "ref-sourcetitle": "NCCN clinical practice guidelines in oncology - breast cancer"
                        },
                        "ce:source-text": "National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology - breast cancer; 2019. Available from: https://www.nccn.org/store/login/login.aspx?ReturnURL=https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Shah M, Nunes MR, Stearns V. CDK4/6 inhibitors: game changers in the management of hormone receptor\u2013positive advanced breast cancer? Oncology 2018;32:216\u201322.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "CDK4/6 inhibitors: game changers in the management of hormone receptor\u2013positive advanced breast cancer?"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85050667314",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "32"},
                                "pagerange": {
                                    "@first": "216",
                                    "@last": "222"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Shah",
                                    "ce:indexed-name": "Shah M"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "MR",
                                    "@_fa": "true",
                                    "ce:surname": "Nunes",
                                    "ce:indexed-name": "Nunes MR"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "V.",
                                    "@_fa": "true",
                                    "ce:surname": "Stearns",
                                    "ce:indexed-name": "Stearns V."
                                }
                            ]},
                            "ref-sourcetitle": "Oncology"
                        },
                        "ce:source-text": "Shah M, Nunes MR, Stearns V. CDK4/6 inhibitors: game changers in the management of hormone receptor\u2013positive advanced breast cancer? Oncology 2018;32:216\u201322."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "KISQALI [Package insert]. East Hanover, NJ: Novartis Pharmaceuticals Corporation; 2019. Available from: https://www.novartis.us/sites/www.novartis.us/files/kisqali.pdf.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.novartis.us/sites/www.novartis.us/files/kisqali.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85100339243",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "KISQALI [Package insert]. East Hanover, NJ: Novartis Pharmaceuticals Corporation"
                        },
                        "ce:source-text": "KISQALI [Package insert]. East Hanover, NJ: Novartis Pharmaceuticals Corporation; 2019. Available from: https://www.novartis.us/sites/www.novartis.us/files/kisqali.pdf."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "IBRANCE [Package insert]. New York, NY: Pfizer; 2019. Available from: http://labeling.pfizer.com/ShowLabeling.aspx?format=PDF&id=2191.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "http://labeling.pfizer.com/ShowLabeling.aspx?format=PDF&id=2191",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85100331564",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "New York, NY: Pfizer",
                            "ref-sourcetitle": "IBRANCE [Package insert]"
                        },
                        "ce:source-text": "IBRANCE [Package insert]. New York, NY: Pfizer; 2019. Available from: http://labeling.pfizer.com/ShowLabeling.aspx?format=PDF&id=2191."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "VERZENIO [Package insert]. Indianapolis, IN: Lilly USA, LLC; 2019. Available from: http://pi.lilly.com/us/verzenio-uspi.pdf.",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "http://pi.lilly.com/us/verzenio-uspi.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85100352108",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "VERZENIO [Package insert]. Indianapolis Lilly USA, LLC"
                        },
                        "ce:source-text": "VERZENIO [Package insert]. Indianapolis, IN: Lilly USA, LLC; 2019. Available from: http://pi.lilly.com/us/verzenio-uspi.pdf."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Department of Health. The Government of Hong Kong Special Administrative Region; 2020. Available from: https://www.drugoffice.gov.hk/eps/do/en/pharmaceutical_trade/search_drug_database.html.",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.drugoffice.gov.hk/eps/do/en/pharmaceutical_trade/search_drug_database.html",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85087285733",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Department of Health",
                            "ref-sourcetitle": "The Government of Hong Kong Special Administrative Region"
                        },
                        "ce:source-text": "Department of Health. The Government of Hong Kong Special Administrative Region; 2020. Available from: https://www.drugoffice.gov.hk/eps/do/en/pharmaceutical_trade/search_drug_database.html."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Taiwan Food and Drug Administration; 2020. Available from: https://www.fda.gov.tw/ENG/index.aspx.",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.fda.gov.tw/ENG/index.aspx",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85100329392",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Taiwan Food and Drug Administration"
                        },
                        "ce:source-text": "Taiwan Food and Drug Administration; 2020. Available from: https://www.fda.gov.tw/ENG/index.aspx."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Suchontan C. Pfizer Ibrance drug to top $2 bn thanks to Asia. The Nation Singapore; 2017. Available from: https://www.nationthailand.com/noname/30333237#:~:text=The%20Esmo%20Oncology%20cancer%20treatment, researchers%20from%20around%20the%20world.",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.nationthailand.com/noname/30333237#:~:text=The%20Esmo%20Oncology%20cancer%20treatment,researchers%20from%20around%20the%20world",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85100345648",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "The Nation Singapore",
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "C.",
                                "@_fa": "true",
                                "ce:surname": "Suchontan",
                                "ce:indexed-name": "Suchontan C."
                            }]},
                            "ref-sourcetitle": "Pfizer Ibrance drug to top $2 bn thanks to Asia"
                        },
                        "ce:source-text": "Suchontan C. Pfizer Ibrance drug to top $2 bn thanks to Asia. The Nation Singapore; 2017. Available from: https://www.nationthailand.com/noname/30333237#:~:text=The%20Esmo%20Oncology%20cancer%20treatment, researchers%20from%20around%20the%20world."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Han-soo L. Lilly aims to reshape Korea's breast cancer treatment market. Korea Biomedical Review; 2019. Available from: http://www.koreabiomed.com/news/articleView.html?idxno=6062#:~:text=Lilly%20Korea%20is%20seeking%20to, Safety%2C%20the%20company%20said%20Friday.",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "http://www.koreabiomed.com/news/articleView.html?idxno=6062#:~:text=Lilly%20Korea%20is%20seeking%20to,Safety%2C%20the%20company%20said%20Friday",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Lilly aims to reshape Korea's breast cancer treatment market"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85100356308",
                                "@idtype": "SGR"
                            }},
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "L.",
                                "@_fa": "true",
                                "ce:surname": "Han-soo",
                                "ce:indexed-name": "Han-soo L."
                            }]},
                            "ref-sourcetitle": "Korea Biomedical Review"
                        },
                        "ce:source-text": "Han-soo L. Lilly aims to reshape Korea's breast cancer treatment market. Korea Biomedical Review; 2019. Available from: http://www.koreabiomed.com/news/articleView.html?idxno=6062#:~:text=Lilly%20Korea%20is%20seeking%20to, Safety%2C%20the%20company%20said%20Friday."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Han-soo L. Novartis\u2019 breast cancer treatment wins regulator's nod. Korea Biomedical Review; 2019. Available from: http://www.koreabiomed.com/news/articleView.html?idxno=6730.",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "http://www.koreabiomed.com/news/articleView.html?idxno=6730",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Novartis\u2019 breast cancer treatment wins regulator's nod"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85100332640",
                                "@idtype": "SGR"
                            }},
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "L.",
                                "@_fa": "true",
                                "ce:surname": "Han-soo",
                                "ce:indexed-name": "Han-soo L."
                            }]},
                            "ref-sourcetitle": "Korea Biomedical Review"
                        },
                        "ce:source-text": "Han-soo L. Novartis\u2019 breast cancer treatment wins regulator's nod. Korea Biomedical Review; 2019. Available from: http://www.koreabiomed.com/news/articleView.html?idxno=6730."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Cancer patients gain easier access to 2 more drugs. The Nation Thailand; 2019. Available from: https://www.nationthailand.com/news/30374065.",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.nationthailand.com/news/30374065",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85100330962",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "The Nation Thailand",
                            "ref-sourcetitle": "Cancer patients gain easier access to 2 more drugs"
                        },
                        "ce:source-text": "Cancer patients gain easier access to 2 more drugs. The Nation Thailand; 2019. Available from: https://www.nationthailand.com/news/30374065."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "CancerGenomeAtlasNetwork.Comprehensivemolecularportraitsofhumanbreast tumours. Nature 2012;490:61\u201370.",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Comprehensivemolecularportraitsofhumanbreast tumours"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84877028141",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "490"},
                                "pagerange": {
                                    "@first": "61",
                                    "@last": "70"
                                }
                            },
                            "ref-text": "CancerGenomeAtlasNetwork",
                            "ref-sourcetitle": "Nature"
                        },
                        "ce:source-text": "CancerGenomeAtlasNetwork.Comprehensivemolecularportraitsofhumanbreast tumours. Nature 2012;490:61\u201370."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Di Leo A, Johnston S, Lee KS, Ciruelos E, Lønning PE, Janni W, et al. Buparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELLE-3): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol 2018;19:87\u2013100.",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Buparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELLE-3): a randomised, double-blind, placebo-controlled, phase 3 trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85040617674",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "19"},
                                "pagerange": {
                                    "@first": "87",
                                    "@last": "100"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Di Leo",
                                        "ce:indexed-name": "Di Leo A"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Johnston",
                                        "ce:indexed-name": "Johnston S"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "KS",
                                        "@_fa": "true",
                                        "ce:surname": "Lee",
                                        "ce:indexed-name": "Lee KS"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Ciruelos",
                                        "ce:indexed-name": "Ciruelos E"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "PE",
                                        "@_fa": "true",
                                        "ce:surname": "Lønning",
                                        "ce:indexed-name": "Lonning PE"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "W",
                                        "@_fa": "true",
                                        "ce:surname": "Janni",
                                        "ce:indexed-name": "Janni W"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Di Leo A, Johnston S, Lee KS, Ciruelos E, Lønning PE, Janni W, et al. Buparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELLE-3): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol 2018;19:87\u2013100."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Mollon L, Aguilar A, Anderson E, Dean JL, Davis L, Warholak TL, et al. A systematic literature review of the prevalence of PIK3CA mutations and mutation hotspots in HRþ/HER2\u2013 metastatic breast cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14\u201318; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018; 78(13 Suppl):Abstract nr 1207.",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "A systematic literature review of the prevalence of PIK3CA mutations and mutation hotspots in HRþ/HER2\u2013 metastatic breast cancer [abstract]"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85065826467",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {"voliss": {
                                "@volume": "78",
                                "@issue": "13"
                            }},
                            "ref-text": "Apr 14\u201318; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018; (Suppl):Abstract nr 1207",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Mollon",
                                        "ce:indexed-name": "Mollon L"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Aguilar",
                                        "ce:indexed-name": "Aguilar A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Anderson",
                                        "ce:indexed-name": "Anderson E"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "JL",
                                        "@_fa": "true",
                                        "ce:surname": "Dean",
                                        "ce:indexed-name": "Dean JL"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Davis",
                                        "ce:indexed-name": "Davis L"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "TL",
                                        "@_fa": "true",
                                        "ce:surname": "Warholak",
                                        "ce:indexed-name": "Warholak TL"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Proceedings of the American Association for Cancer Research Annual Meeting 2018"
                        },
                        "ce:source-text": "Mollon L, Aguilar A, Anderson E, Dean JL, Davis L, Warholak TL, et al. A systematic literature review of the prevalence of PIK3CA mutations and mutation hotspots in HRþ/HER2\u2013 metastatic breast cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14\u201318; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018; 78(13 Suppl):Abstract nr 1207."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Tolaney S, Toi M, Neven P, Sohn J, Grischke E-M, Llombart-Cussac A, et al. Clinical significance of PIK3CA and ESR1 mutations in ctDNA and FFPE samples from the MONARCH 2 study of abemaciclib plus fulvestrant [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29\u2013Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 4458.",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Clinical significance of PIK3CA and ESR1 mutations in ctDNA and FFPE samples from the MONARCH 2 study of abemaciclib plus fulvestrant [abstract]"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85100351665",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {"voliss": {
                                "@volume": "79",
                                "@issue": "13"
                            }},
                            "ref-text": "Mar 29\u2013Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;(Suppl):Abstract nr 4458",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Tolaney",
                                        "ce:indexed-name": "Tolaney S"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Toi",
                                        "ce:indexed-name": "Toi M"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Neven",
                                        "ce:indexed-name": "Neven P"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Sohn",
                                        "ce:indexed-name": "Sohn J"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "E-M",
                                        "@_fa": "true",
                                        "ce:surname": "Grischke",
                                        "ce:indexed-name": "Grischke E-M"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Llombart-Cussac",
                                        "ce:indexed-name": "Llombart-Cussac A"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Proceedings of the American Association for Cancer Research Annual Meeting 2019"
                        },
                        "ce:source-text": "Tolaney S, Toi M, Neven P, Sohn J, Grischke E-M, Llombart-Cussac A, et al. Clinical significance of PIK3CA and ESR1 mutations in ctDNA and FFPE samples from the MONARCH 2 study of abemaciclib plus fulvestrant [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29\u2013Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 4458."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Moynahan ME, Chen D, He W, Sung P, Samoila A, You D, et al. Correlation between PIK3CA mutations in cell-free DNA and everolimus efficacy in HR(þ), HER2(-) advanced breast cancer: results from BOLERO-2. Br J Cancer 2017;116:726\u201330.",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Correlation between PIK3CA mutations in cell-free DNA and everolimus efficacy in HR(þ), HER2(-) advanced breast cancer: results from BOLERO-2"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85011875111",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "116"},
                                "pagerange": {
                                    "@first": "726",
                                    "@last": "730"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "ME",
                                        "@_fa": "true",
                                        "ce:surname": "Moynahan",
                                        "ce:indexed-name": "Moynahan ME"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Chen",
                                        "ce:indexed-name": "Chen D"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "W",
                                        "@_fa": "true",
                                        "ce:surname": "He",
                                        "ce:indexed-name": "He W"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Sung",
                                        "ce:indexed-name": "Sung P"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Samoila",
                                        "ce:indexed-name": "Samoila A"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "You",
                                        "ce:indexed-name": "You D"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Br J Cancer"
                        },
                        "ce:source-text": "Moynahan ME, Chen D, He W, Sung P, Samoila A, You D, et al. Correlation between PIK3CA mutations in cell-free DNA and everolimus efficacy in HR(þ), HER2(-) advanced breast cancer: results from BOLERO-2. Br J Cancer 2017;116:726\u201330."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Engelman JA, Luo J, Cantley LC. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 2006;7:606\u201319.",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism"},
                            "refd-itemidlist": {"itemid": {
                                "$": "33746257209",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {
                                    "@first": "606",
                                    "@last": "619"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "JA",
                                    "@_fa": "true",
                                    "ce:surname": "Engelman",
                                    "ce:indexed-name": "Engelman JA"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Luo",
                                    "ce:indexed-name": "Luo J"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "LC.",
                                    "@_fa": "true",
                                    "ce:surname": "Cantley",
                                    "ce:indexed-name": "Cantley LC."
                                }
                            ]},
                            "ref-sourcetitle": "Nat Rev Genet"
                        },
                        "ce:source-text": "Engelman JA, Luo J, Cantley LC. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 2006;7:606\u201319."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "QinH,LiuL,SunS,ZhangD,ShengJ,LiB,etal.TheimpactofPI3Kinhibitorson breast cancer cell and its tumor microenvironment. PeerJ 2018;6:e5092.",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "TheimpactofPI3Kinhibitorson breast cancer cell and its tumor microenvironment"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85048831480",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "6"},
                                "pagerange": {"@first": "e5092"}
                            },
                            "ref-text": "etal",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "H",
                                    "@_fa": "true",
                                    "ce:surname": "Qin",
                                    "ce:indexed-name": "Qin H"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "L",
                                    "@_fa": "true",
                                    "ce:surname": "Liu",
                                    "ce:indexed-name": "Liu L"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Sun",
                                    "ce:indexed-name": "Sun S"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "D",
                                    "@_fa": "true",
                                    "ce:surname": "Zhang",
                                    "ce:indexed-name": "Zhang D"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Sheng",
                                    "ce:indexed-name": "Sheng J"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "B",
                                    "@_fa": "true",
                                    "ce:surname": "Li",
                                    "ce:indexed-name": "Li B"
                                }
                            ]},
                            "ref-sourcetitle": "PeerJ"
                        },
                        "ce:source-text": "QinH,LiuL,SunS,ZhangD,ShengJ,LiB,etal.TheimpactofPI3Kinhibitorson breast cancer cell and its tumor microenvironment. PeerJ 2018;6:e5092."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Andre F, Ciruelos E, Rubovszky G, Campone M, Rugo HS, Iwata H, et al. Alpelisib for PIK3CA-mutated, hormone receptor\u2013positive advanced breast cancer. N Engl J Med 2019;380:1929\u201340.",
                        "@id": "31",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Alpelisib for PIK3CA-mutated, hormone receptor\u2013positive advanced breast cancer"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85065812556",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "380"},
                                "pagerange": {
                                    "@first": "1929",
                                    "@last": "1940"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Andre",
                                        "ce:indexed-name": "Andre F"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Ciruelos",
                                        "ce:indexed-name": "Ciruelos E"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Rubovszky",
                                        "ce:indexed-name": "Rubovszky G"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Campone",
                                        "ce:indexed-name": "Campone M"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "HS",
                                        "@_fa": "true",
                                        "ce:surname": "Rugo",
                                        "ce:indexed-name": "Rugo HS"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "H",
                                        "@_fa": "true",
                                        "ce:surname": "Iwata",
                                        "ce:indexed-name": "Iwata H"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Andre F, Ciruelos E, Rubovszky G, Campone M, Rugo HS, Iwata H, et al. Alpelisib for PIK3CA-mutated, hormone receptor\u2013positive advanced breast cancer. N Engl J Med 2019;380:1929\u201340."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Fritsch C, Huang A, Chatenay-Rivauday C, Schnell C, Reddy A, Liu M, et al. Characterization of the novel and specific PI3Ka inhibitor NVP-BYL719 and development of the patient stratification strategy for clinical trials. Mol Cancer Ther 2014;13:1117\u201329.",
                        "@id": "32",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Characterization of the novel and specific PI3Ka inhibitor NVP-BYL719 and development of the patient stratification strategy for clinical trials"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84899785427",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {
                                    "@first": "1117",
                                    "@last": "1129"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Fritsch",
                                        "ce:indexed-name": "Fritsch C"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Huang",
                                        "ce:indexed-name": "Huang A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Chatenay-Rivauday",
                                        "ce:indexed-name": "Chatenay-Rivauday C"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Schnell",
                                        "ce:indexed-name": "Schnell C"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Reddy",
                                        "ce:indexed-name": "Reddy A"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Liu",
                                        "ce:indexed-name": "Liu M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Mol Cancer Ther"
                        },
                        "ce:source-text": "Fritsch C, Huang A, Chatenay-Rivauday C, Schnell C, Reddy A, Liu M, et al. Characterization of the novel and specific PI3Ka inhibitor NVP-BYL719 and development of the patient stratification strategy for clinical trials. Mol Cancer Ther 2014;13:1117\u201329."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Baselga J, Im S-A, Iwata H, Cortes J, De Laurentiis M, Jiang Z, et al. Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol 2017;18:904\u201316.",
                        "@id": "33",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85020030586",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "18"},
                                "pagerange": {
                                    "@first": "904",
                                    "@last": "916"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Baselga",
                                        "ce:indexed-name": "Baselga J"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S-A",
                                        "@_fa": "true",
                                        "ce:surname": "Im",
                                        "ce:indexed-name": "Im S-A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H",
                                        "@_fa": "true",
                                        "ce:surname": "Iwata",
                                        "ce:indexed-name": "Iwata H"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Cortes",
                                        "ce:indexed-name": "Cortes J"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "De Laurentiis",
                                        "ce:indexed-name": "De Laurentiis M"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "Z",
                                        "@_fa": "true",
                                        "ce:surname": "Jiang",
                                        "ce:indexed-name": "Jiang Z"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Baselga J, Im S-A, Iwata H, Cortes J, De Laurentiis M, Jiang Z, et al. Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol 2017;18:904\u201316."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Cardoso F, Costa A, Senkus E, Aapro M, Andre F, Barrios CH, et al. 3rd ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 3). Ann Oncol 2017;28:16\u201333.",
                        "@id": "34",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "3rd ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 3)"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85015780252",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "28"},
                                "pagerange": {
                                    "@first": "16",
                                    "@last": "33"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Cardoso",
                                        "ce:indexed-name": "Cardoso F"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Costa",
                                        "ce:indexed-name": "Costa A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Senkus",
                                        "ce:indexed-name": "Senkus E"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Aapro",
                                        "ce:indexed-name": "Aapro M"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Andre",
                                        "ce:indexed-name": "Andre F"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "CH",
                                        "@_fa": "true",
                                        "ce:surname": "Barrios",
                                        "ce:indexed-name": "Barrios CH"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Cardoso F, Costa A, Senkus E, Aapro M, Andre F, Barrios CH, et al. 3rd ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 3). Ann Oncol 2017;28:16\u201333."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Carlson RW, Allred DC, Anderson BO, Burstein HJ, Edge SB, Farrar WB, et al. Metastatic breast cancer, version 1.2012: featured updates to the NCCN guidelines. J Natl Compr Canc Netw 2012;10:821\u20139.",
                        "@id": "35",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Metastatic breast cancer, version 1.2012: featured updates to the NCCN guidelines"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84865341798",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "10"},
                                "pagerange": {
                                    "@first": "821",
                                    "@last": "829"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "RW",
                                        "@_fa": "true",
                                        "ce:surname": "Carlson",
                                        "ce:indexed-name": "Carlson RW"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "DC",
                                        "@_fa": "true",
                                        "ce:surname": "Allred",
                                        "ce:indexed-name": "Allred DC"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "BO",
                                        "@_fa": "true",
                                        "ce:surname": "Anderson",
                                        "ce:indexed-name": "Anderson BO"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "HJ",
                                        "@_fa": "true",
                                        "ce:surname": "Burstein",
                                        "ce:indexed-name": "Burstein HJ"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "SB",
                                        "@_fa": "true",
                                        "ce:surname": "Edge",
                                        "ce:indexed-name": "Edge SB"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "WB",
                                        "@_fa": "true",
                                        "ce:surname": "Farrar",
                                        "ce:indexed-name": "Farrar WB"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Natl Compr Canc Netw"
                        },
                        "ce:source-text": "Carlson RW, Allred DC, Anderson BO, Burstein HJ, Edge SB, Farrar WB, et al. Metastatic breast cancer, version 1.2012: featured updates to the NCCN guidelines. J Natl Compr Canc Netw 2012;10:821\u20139."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Klijn JG, Blamey RW, Boccardo F, Tominaga T, Duchateau L, Sylvester R, et al. Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials. J Clin Oncol 2001; 19:343\u201353.",
                        "@id": "36",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2001"},
                            "ref-title": {"ref-titletext": "Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0035862149",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "19"},
                                "pagerange": {
                                    "@first": "343",
                                    "@last": "353"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JG",
                                        "@_fa": "true",
                                        "ce:surname": "Klijn",
                                        "ce:indexed-name": "Klijn JG"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "RW",
                                        "@_fa": "true",
                                        "ce:surname": "Blamey",
                                        "ce:indexed-name": "Blamey RW"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Boccardo",
                                        "ce:indexed-name": "Boccardo F"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Tominaga",
                                        "ce:indexed-name": "Tominaga T"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Duchateau",
                                        "ce:indexed-name": "Duchateau L"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Sylvester",
                                        "ce:indexed-name": "Sylvester R"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Klijn JG, Blamey RW, Boccardo F, Tominaga T, Duchateau L, Sylvester R, et al. Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials. J Clin Oncol 2001; 19:343\u201353."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Ando Y, Iwasa S, Takahashi S, Saka H, Kakizume T, Natsume K, et al. Phase I study of alpelisib (BYL719), an alpha-specific PI3K inhibitor, in Japanese patients with advanced solid tumors. Cancer Sci 2019;110:1021\u201331.",
                        "@id": "37",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Phase I study of alpelisib (BYL719), an alpha-specific PI3K inhibitor, in Japanese patients with advanced solid tumors"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85060981048",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "110"},
                                "pagerange": {
                                    "@first": "1021",
                                    "@last": "1031"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Ando",
                                        "ce:indexed-name": "Ando Y"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Iwasa",
                                        "ce:indexed-name": "Iwasa S"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Takahashi",
                                        "ce:indexed-name": "Takahashi S"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "H",
                                        "@_fa": "true",
                                        "ce:surname": "Saka",
                                        "ce:indexed-name": "Saka H"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Kakizume",
                                        "ce:indexed-name": "Kakizume T"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Natsume",
                                        "ce:indexed-name": "Natsume K"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Sci"
                        },
                        "ce:source-text": "Ando Y, Iwasa S, Takahashi S, Saka H, Kakizume T, Natsume K, et al. Phase I study of alpelisib (BYL719), an alpha-specific PI3K inhibitor, in Japanese patients with advanced solid tumors. Cancer Sci 2019;110:1021\u201331."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "AndoY,Inada-InoueM,MitsumaA,YoshinoT,OhtsuA,SuenagaN,etal.Phase I dose-escalation study of buparlisib (BKM120), an oral pan-class I PI3K inhibitor, in Japanese patients with advanced solid tumors. Cancer Sci 2014; 105:347\u201353.",
                        "@id": "38",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Phase I dose-escalation study of buparlisib (BKM120), an oral pan-class I PI3K inhibitor, in Japanese patients with advanced solid tumors"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84895517907",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "105"},
                                "pagerange": {
                                    "@first": "347",
                                    "@last": "353"
                                }
                            },
                            "ref-text": "etal",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "Y",
                                    "@_fa": "true",
                                    "ce:surname": "Ando",
                                    "ce:indexed-name": "Ando Y"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Inada-Inoue",
                                    "ce:indexed-name": "Inada-Inoue M"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A",
                                    "@_fa": "true",
                                    "ce:surname": "Mitsuma",
                                    "ce:indexed-name": "Mitsuma A"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "T",
                                    "@_fa": "true",
                                    "ce:surname": "Yoshino",
                                    "ce:indexed-name": "Yoshino T"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "A",
                                    "@_fa": "true",
                                    "ce:surname": "Ohtsu",
                                    "ce:indexed-name": "Ohtsu A"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "N",
                                    "@_fa": "true",
                                    "ce:surname": "Suenaga",
                                    "ce:indexed-name": "Suenaga N"
                                }
                            ]},
                            "ref-sourcetitle": "Cancer Sci"
                        },
                        "ce:source-text": "AndoY,Inada-InoueM,MitsumaA,YoshinoT,OhtsuA,SuenagaN,etal.Phase I dose-escalation study of buparlisib (BKM120), an oral pan-class I PI3K inhibitor, in Japanese patients with advanced solid tumors. Cancer Sci 2014; 105:347\u201353."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "PIQRAY [Package insert]. East Hanover NNPC. Available from: https://www.pharma.us.novartis.com/sites/www.pharma.us.novartis.com/files/piqray.pdf.",
                        "@id": "39",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.pharma.us.novartis.com/sites/www.pharma.us.novartis.com/files/piqray.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85100347901",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "PIQRAY [Package insert]. East Hanover NNPC"
                        },
                        "ce:source-text": "PIQRAY [Package insert]. East Hanover NNPC. Available from: https://www.pharma.us.novartis.com/sites/www.pharma.us.novartis.com/files/piqray.pdf."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Khan KH, Wong M, Rihawi K, Bodla S, Morganstein D, Banerji U, et al. Hyperglycemia and phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR) inhibitors in phase I trials: incidence, predictive factors, and management. Oncologist 2016;21:855\u201360.",
                        "@id": "40",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Hyperglycemia and phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR) inhibitors in phase I trials: incidence, predictive factors, and management"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84978511607",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "21"},
                                "pagerange": {
                                    "@first": "855",
                                    "@last": "860"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "KH",
                                        "@_fa": "true",
                                        "ce:surname": "Khan",
                                        "ce:indexed-name": "Khan KH"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Wong",
                                        "ce:indexed-name": "Wong M"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Rihawi",
                                        "ce:indexed-name": "Rihawi K"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Bodla",
                                        "ce:indexed-name": "Bodla S"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Morganstein",
                                        "ce:indexed-name": "Morganstein D"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "U",
                                        "@_fa": "true",
                                        "ce:surname": "Banerji",
                                        "ce:indexed-name": "Banerji U"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oncologist"
                        },
                        "ce:source-text": "Khan KH, Wong M, Rihawi K, Bodla S, Morganstein D, Banerji U, et al. Hyperglycemia and phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR) inhibitors in phase I trials: incidence, predictive factors, and management. Oncologist 2016;21:855\u201360."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Schindler K, Abraham R, Shah PD, Chandarlapaty S, Paik PK, Bell-McGuinn K, et al. Clinical and histologic characterization of dermatologic adverse events from the pan-PI3K inhibitor buparlisib (BKM-120). J Clin Oncol 32:15s, 2014 (suppl; abstr e20639).",
                        "@id": "41",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Clinical and histologic characterization of dermatologic adverse events from the pan-PI3K inhibitor buparlisib (BKM-120)"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84993988733",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "32"},
                                "pagerange": {"@first": "15s"}
                            },
                            "ref-text": "(suppl; abstr e20639)",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Schindler",
                                        "ce:indexed-name": "Schindler K"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Abraham",
                                        "ce:indexed-name": "Abraham R"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "PD",
                                        "@_fa": "true",
                                        "ce:surname": "Shah",
                                        "ce:indexed-name": "Shah PD"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Chandarlapaty",
                                        "ce:indexed-name": "Chandarlapaty S"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "PK",
                                        "@_fa": "true",
                                        "ce:surname": "Paik",
                                        "ce:indexed-name": "Paik PK"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Bell-McGuinn",
                                        "ce:indexed-name": "Bell-McGuinn K"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Schindler K, Abraham R, Shah PD, Chandarlapaty S, Paik PK, Bell-McGuinn K, et al. Clinical and histologic characterization of dermatologic adverse events from the pan-PI3K inhibitor buparlisib (BKM-120). J Clin Oncol 32:15s, 2014 (suppl; abstr e20639)."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Curry JL, Torres-Cabala CA, Kim KB, Tetzlaff MT, Duvic M, Tsai KY, et al. Dermatologic toxicities to targeted cancer therapy: shared clinical and histologic adverse skin reactions. Int J Dermatol 2014;53:376\u201384.",
                        "@id": "42",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Dermatologic toxicities to targeted cancer therapy: shared clinical and histologic adverse skin reactions"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84894237511",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "53"},
                                "pagerange": {
                                    "@first": "376",
                                    "@last": "384"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JL",
                                        "@_fa": "true",
                                        "ce:surname": "Curry",
                                        "ce:indexed-name": "Curry JL"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "CA",
                                        "@_fa": "true",
                                        "ce:surname": "Torres-Cabala",
                                        "ce:indexed-name": "Torres-Cabala CA"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "KB",
                                        "@_fa": "true",
                                        "ce:surname": "Kim",
                                        "ce:indexed-name": "Kim KB"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "MT",
                                        "@_fa": "true",
                                        "ce:surname": "Tetzlaff",
                                        "ce:indexed-name": "Tetzlaff MT"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Duvic",
                                        "ce:indexed-name": "Duvic M"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "KY",
                                        "@_fa": "true",
                                        "ce:surname": "Tsai",
                                        "ce:indexed-name": "Tsai KY"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Int J Dermatol"
                        },
                        "ce:source-text": "Curry JL, Torres-Cabala CA, Kim KB, Tetzlaff MT, Duvic M, Tsai KY, et al. Dermatologic toxicities to targeted cancer therapy: shared clinical and histologic adverse skin reactions. Int J Dermatol 2014;53:376\u201384."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Furet P, Guagnano V, Fairhurst RA, Imbach-Weese P, Bruce I, Knapp M, et al. Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation. Bioorg Med Chem Lett 2013;23: 3741\u20138.",
                        "@id": "43",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84878836487",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "23"},
                                "pagerange": {
                                    "@first": "3741",
                                    "@last": "3748"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Furet",
                                        "ce:indexed-name": "Furet P"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "V",
                                        "@_fa": "true",
                                        "ce:surname": "Guagnano",
                                        "ce:indexed-name": "Guagnano V"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "RA",
                                        "@_fa": "true",
                                        "ce:surname": "Fairhurst",
                                        "ce:indexed-name": "Fairhurst RA"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Imbach-Weese",
                                        "ce:indexed-name": "Imbach-Weese P"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "I",
                                        "@_fa": "true",
                                        "ce:surname": "Bruce",
                                        "ce:indexed-name": "Bruce I"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Knapp",
                                        "ce:indexed-name": "Knapp M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Bioorg Med Chem Lett"
                        },
                        "ce:source-text": "Furet P, Guagnano V, Fairhurst RA, Imbach-Weese P, Bruce I, Knapp M, et al. Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation. Bioorg Med Chem Lett 2013;23: 3741\u20138."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Taipei",
            "@id": "60031913",
            "affilname": "Chang Gung Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031913",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Seoul",
            "@id": "60020857",
            "affilname": "Samsung Medical Center, Sungkyunkwan university",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020857",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "New Taipei City",
            "@id": "60211913",
            "affilname": "Taipei Medical University Shuang-Ho Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60211913",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Seoul",
            "@id": "60115402",
            "affilname": "Yonsei Cancer Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60115402",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Seongnam",
            "@id": "60098516",
            "affilname": "Seoul National University Bundang Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60098516",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Taipei",
            "@id": "60073385",
            "affilname": "National Taiwan University Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073385",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Taipei",
            "@id": "60069716",
            "affilname": "National Yang-Ming University Taiwan",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60069716",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Taipei",
            "@id": "60029238",
            "affilname": "Mackay Memorial Hospital Taiwan",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029238",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Taipei",
            "@id": "60013314",
            "affilname": "Veterans General Hospital-Taipei",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60013314",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Basel",
            "@id": "60009968",
            "affilname": "Novartis International AG",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009968",
            "affiliation-country": "Switzerland"
        },
        {
            "affiliation-city": "Seoul",
            "@id": "60006240",
            "affilname": "University of Ulsan College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006240",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Taichung",
            "@id": "60006121",
            "affilname": "Veterans General Hospital-Taichung Taiwan",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006121",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Chaing Mai",
            "@id": "60000881",
            "affilname": "Chiang Mai University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Goyang",
            "@id": "124204628",
            "affilname": "National Cancer Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/124204628",
            "affiliation-country": "South Korea"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85100350018",
        "dc:description": "Purpose: This study reports the MTD, recommended phase 2 ose (RP2D), and preliminary efficacy of alpelisib or buparlisib used n combination with tamoxifen plus goserelin in premenopausal atients with hormone receptor\u2013positive (HRþ), HER2-negative HER2) advanced breast cancer (ABC). Patients and Methods: This study enrolled premenopausal women with HRþ, HER2 ABC. Patients received tamoxifen (20 mg nce daily) and goserelin acetate (3.6 mg every 28 days) with either lpelisib (350 mg once daily; n ¼ 16) or buparlisib (100 mg once aily; n ¼ 13) in 28-day cycles until MTD was observed. Results: The criteria for MTD were not met for both alpelisib and uparlisib. The RP2D of alpelisib and buparlisib in combination with tamoxifen and goserelin were 350 mg and 100 mg, respectively. oth combinations met protocol-specified criteria for tolerability. The most common grade 3/4 treatment-emergent adverse events (TEAE) were hypokalemia (12.5%), hyperglycemia (6.3%), and rash (6.3%) for alpelisib and alanine aminotransferase increase (30.8%), aspartate aminotransferase increase (23.1%), and anxiety (15.4%) for buparlisib. TEAEs led to treatment discontinuation in 18.8% and 53.8% of alpelisib- and buparlisib-treated patients, respectively. Progression-free survival was 25.2 months in the alpelisib group and 20.6 months in the buparlisib group. Conclusions: The RP2Ds of alpelisib and buparlisib were 350 mg and 100 mg, respectively. No unexpected safety findings were reported. Although an early-phase study, data suggest that alpelisib plus endocrine therapy may be a potentially efficacious treatment that warrants further evaluation for premenopausal patients with HRþ, HER2 ABC.",
        "pubmed-id": "32718997",
        "prism:coverDate": "2021-01-15",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85100350018",
        "dc:creator": {"author": [{
            "ce:given-name": "Yen-Shen",
            "preferred-name": {
                "ce:given-name": "Yen Shen",
                "ce:initials": "Y.S.",
                "ce:surname": "Lu",
                "ce:indexed-name": "Lu Y.S."
            },
            "@seq": "1",
            "ce:initials": "Y.-S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60073385",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073385"
            },
            "ce:surname": "Lu",
            "@auid": "7405478996",
            "author-url": "https://api.elsevier.com/content/author/author_id/7405478996",
            "ce:indexed-name": "Lu Y.-S."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85100350018"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85100350018&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85100350018&origin=inward"
            }
        ],
        "source-id": "29263",
        "citedby-count": "21",
        "prism:volume": "27",
        "subtype": "ar",
        "dc:title": "A phase ib study of alpelisib or buparlisib combined with tamoxifen plus goserelin in premenopausal women with HR-positive HER2-negative advanced breast cancer",
        "openaccess": "1",
        "prism:issn": "15573265 10780432",
        "publishercopyright": "© 2020 American Association for Cancer Research.",
        "prism:issueIdentifier": "2",
        "subtypeDescription": "Article",
        "prism:publicationName": "Clinical Cancer Research",
        "prism:pageRange": "408-417",
        "prism:endingPage": "417",
        "openaccessFlag": "true",
        "prism:doi": "10.1158/1078-0432.CCR-20-1008",
        "prism:startingPage": "408",
        "dc:identifier": "SCOPUS_ID:85100350018",
        "dc:publisher": "American Association for Cancer Research Inc."
    },
    "idxterms": {"mainterm": [
        {
            "$": "Aminopyridines",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Antineoplastic Combined Chemotherapy Protocols",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Breast Neoplasms",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Cyclin-Dependent Kinase 4",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Female",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Goserelin",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Morpholines",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Phosphatidylinositol 3-Kinases",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Receptor, ErbB-2",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Tamoxifen",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Thiazoles",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": null,
    "subject-areas": {"subject-area": [{
        "@_fa": "true",
        "$": "Medicine (all)",
        "@code": "2700",
        "@abbrev": "MEDI"
    }]},
    "authors": {"author": [
        {
            "ce:given-name": "Yen-Shen",
            "preferred-name": {
                "ce:given-name": "Yen Shen",
                "ce:initials": "Y.S.",
                "ce:surname": "Lu",
                "ce:indexed-name": "Lu Y.S."
            },
            "@seq": "1",
            "ce:initials": "Y.-S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60073385",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073385"
            },
            "ce:surname": "Lu",
            "@auid": "7405478996",
            "author-url": "https://api.elsevier.com/content/author/author_id/7405478996",
            "ce:indexed-name": "Lu Y.-S."
        },
        {
            "ce:given-name": "Keun Seok",
            "preferred-name": {
                "ce:given-name": "Keun Seok",
                "ce:initials": "K.S.",
                "ce:surname": "Lee",
                "ce:indexed-name": "Lee K.S."
            },
            "@seq": "2",
            "ce:initials": "K.S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "124204628",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/124204628"
            },
            "ce:surname": "Lee",
            "@auid": "17137276100",
            "author-url": "https://api.elsevier.com/content/author/author_id/17137276100",
            "ce:indexed-name": "Lee K.S."
        },
        {
            "ce:given-name": "Tsu-Yi",
            "preferred-name": {
                "ce:given-name": "Tsu Yi",
                "ce:initials": "T.Y.",
                "ce:surname": "Chao",
                "ce:indexed-name": "Chao T.Y."
            },
            "@seq": "3",
            "ce:initials": "T.-Y.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60211913",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60211913"
            },
            "ce:surname": "Chao",
            "@auid": "36766329400",
            "author-url": "https://api.elsevier.com/content/author/author_id/36766329400",
            "ce:indexed-name": "Chao T.-Y."
        },
        {
            "ce:given-name": "Ling-Ming",
            "preferred-name": {
                "ce:given-name": "Ling Ming",
                "ce:initials": "L.M.",
                "ce:surname": "Tseng",
                "ce:indexed-name": "Tseng L.M."
            },
            "@seq": "4",
            "ce:initials": "L.-M.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60013314",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60013314"
                },
                {
                    "@id": "60069716",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60069716"
                }
            ],
            "ce:surname": "Tseng",
            "@auid": "7201526690",
            "author-url": "https://api.elsevier.com/content/author/author_id/7201526690",
            "ce:indexed-name": "Tseng L.-M."
        },
        {
            "ce:given-name": "Imjai",
            "preferred-name": {
                "ce:given-name": "Imjai",
                "ce:initials": "I.",
                "ce:surname": "Chitapanarux",
                "ce:indexed-name": "Chitapanarux I."
            },
            "@seq": "5",
            "ce:initials": "I.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60000881",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881"
            },
            "ce:surname": "Chitapanarux",
            "@auid": "55937935900",
            "author-url": "https://api.elsevier.com/content/author/author_id/55937935900",
            "ce:indexed-name": "Chitapanarux I."
        },
        {
            "ce:given-name": "Shin-Cheh",
            "preferred-name": {
                "ce:given-name": "Shin Cheh",
                "ce:initials": "S.C.",
                "ce:surname": "Chen",
                "ce:indexed-name": "Chen S.C."
            },
            "@seq": "6",
            "ce:initials": "S.-C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60031913",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031913"
            },
            "ce:surname": "Chen",
            "@auid": "7410261626",
            "author-url": "https://api.elsevier.com/content/author/author_id/7410261626",
            "ce:indexed-name": "Chen S.-C."
        },
        {
            "ce:given-name": "Chien-Ting",
            "preferred-name": {
                "ce:given-name": "Chien Ting",
                "ce:initials": "C.T.",
                "ce:surname": "Liu",
                "ce:indexed-name": "Liu C.T."
            },
            "@seq": "7",
            "ce:initials": "C.-T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60031913",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031913"
            },
            "ce:surname": "Liu",
            "@auid": "55324343100",
            "author-url": "https://api.elsevier.com/content/author/author_id/55324343100",
            "ce:indexed-name": "Liu C.-T."
        },
        {
            "ce:given-name": "Joohyuk",
            "preferred-name": {
                "ce:given-name": "Joohyuk",
                "ce:initials": "J.",
                "ce:surname": "Sohn",
                "ce:indexed-name": "Sohn J."
            },
            "@seq": "8",
            "ce:initials": "J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60115402",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60115402"
            },
            "ce:surname": "Sohn",
            "@auid": "15045889800",
            "author-url": "https://api.elsevier.com/content/author/author_id/15045889800",
            "ce:indexed-name": "Sohn J."
        },
        {
            "ce:given-name": "Jee Hyun",
            "preferred-name": {
                "ce:given-name": "Jee Hyun",
                "ce:initials": "J.H.",
                "ce:surname": "Kim",
                "ce:indexed-name": "Kim J.H."
            },
            "@seq": "9",
            "ce:initials": "J.H.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60098516",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60098516"
            },
            "ce:surname": "Kim",
            "@auid": "56004266300",
            "author-url": "https://api.elsevier.com/content/author/author_id/56004266300",
            "ce:indexed-name": "Kim J.H."
        },
        {
            "ce:given-name": "Yuan-Ching",
            "preferred-name": {
                "ce:given-name": "Yuan Ching",
                "ce:initials": "Y.C.",
                "ce:surname": "Chang",
                "ce:indexed-name": "Chang Y.C."
            },
            "@seq": "10",
            "ce:initials": "Y.-C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60029238",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029238"
            },
            "ce:surname": "Chang",
            "@auid": "7501844206",
            "author-url": "https://api.elsevier.com/content/author/author_id/7501844206",
            "ce:indexed-name": "Chang Y.-C."
        },
        {
            "ce:given-name": "Youngsen",
            "preferred-name": {
                "ce:given-name": "Youngsen",
                "ce:initials": "Y.",
                "ce:surname": "Yang",
                "ce:indexed-name": "Yang Y."
            },
            "@seq": "11",
            "ce:initials": "Y.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60006121",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006121"
            },
            "ce:surname": "Yang",
            "@auid": "16403762600",
            "author-url": "https://api.elsevier.com/content/author/author_id/16403762600",
            "ce:indexed-name": "Yang Y."
        },
        {
            "ce:given-name": "Kanjana",
            "preferred-name": {
                "ce:given-name": "Kanjana",
                "ce:initials": "K.",
                "ce:surname": "Shotelersuk",
                "ce:indexed-name": "Shotelersuk K."
            },
            "@seq": "12",
            "ce:initials": "K.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Shotelersuk",
            "@auid": "6602969622",
            "author-url": "https://api.elsevier.com/content/author/author_id/6602969622",
            "ce:indexed-name": "Shotelersuk K."
        },
        {
            "ce:given-name": "Kyung Hae",
            "preferred-name": {
                "ce:given-name": "Kyung Hae",
                "ce:initials": "K.H.",
                "ce:surname": "Jung",
                "ce:indexed-name": "Jung K.H."
            },
            "@seq": "13",
            "ce:initials": "K.H.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60006240",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006240"
            },
            "ce:surname": "Jung",
            "@auid": "15765006000",
            "author-url": "https://api.elsevier.com/content/author/author_id/15765006000",
            "ce:indexed-name": "Jung K.H."
        },
        {
            "ce:given-name": "Roberta",
            "preferred-name": {
                "ce:given-name": "Roberta",
                "ce:initials": "R.",
                "ce:surname": "Valenti",
                "ce:indexed-name": "Valenti R."
            },
            "@seq": "14",
            "ce:initials": "R.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60009968",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009968"
            },
            "ce:surname": "Valenti",
            "@auid": "57221831113",
            "author-url": "https://api.elsevier.com/content/author/author_id/57221831113",
            "ce:indexed-name": "Valenti R."
        },
        {
            "ce:given-name": "Cassandra",
            "preferred-name": {
                "ce:given-name": "Cassandra",
                "ce:initials": "C.",
                "ce:surname": "Slader",
                "ce:indexed-name": "Slader C."
            },
            "@seq": "15",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60009968",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009968"
            },
            "ce:surname": "Slader",
            "@auid": "57220568979",
            "author-url": "https://api.elsevier.com/content/author/author_id/57220568979",
            "ce:indexed-name": "Slader C."
        },
        {
            "ce:given-name": "Melissa",
            "preferred-name": {
                "ce:given-name": "Melissa",
                "ce:initials": "M.",
                "ce:surname": "Gao",
                "ce:indexed-name": "Gao M."
            },
            "@seq": "16",
            "ce:initials": "M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60009968",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009968"
            },
            "ce:surname": "Gao",
            "@auid": "57221834242",
            "author-url": "https://api.elsevier.com/content/author/author_id/57221834242",
            "ce:indexed-name": "Gao M."
        },
        {
            "ce:given-name": "Yeon Hee",
            "preferred-name": {
                "ce:given-name": "Yeon Hee",
                "ce:initials": "Y.H.",
                "ce:surname": "Park",
                "ce:indexed-name": "Park Y.H."
            },
            "@seq": "17",
            "ce:initials": "Y.H.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60020857",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020857"
                },
                {
                    "@id": "60020857",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020857"
                }
            ],
            "ce:surname": "Park",
            "@auid": "56590167700",
            "author-url": "https://api.elsevier.com/content/author/author_id/56590167700",
            "ce:indexed-name": "Park Y.H."
        }
    ]}
}}